相关实验视频

Updated: Jun 15, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

不同生物药物治疗长期鼻炎与鼻的疗效:一个网络元分析

Huikang Wang^1,2,3, Xinjun Xu^1,2,3, Zhaoyang Lu^2,3,4

¹Department of Otorhinolaryngology, Head and Neck Surgery, Yantai Yuhuangding Hospital, Yantai, QingdaoUniversity, China.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

|August 26, 2024

概括

杜皮卢马布是慢性鼻炎与鼻息肉 (CRSwNP) 的最有效的生物治疗方法,显著改善了鼻息肉得分和症状. 这一发现解决了关于生物制剂在CRSwNP管理中的有效性正在进行的辩论.

科学领域:

免疫学和过敏学
耳鼻喉科耳鼻喉科耳鼻喉科
药理学药理学是指药理学的学科.

背景情况:

目前正在讨论使用生物药物治疗带鼻息肉的慢性鼻炎 (CRSwNP).
需要系统地评估不同生物制剂在治疗CRSwNP时的比较有效性.

研究的目的:

评估各种生物制剂在治疗具有鼻息肉的慢性鼻炎 (CRSwNP) 的有效性.
使用网络元分析来比较不同生物制剂的疗效.

主要方法:

在2023年12月20日之前进行了系统和手动的文献搜索.
两位独立作者进行了研究选,评估和数据提取.
在19项纳入研究中,使用STATA 14软件进行了网络元分析.

主要成果:

杜皮卢马布,奥马利祖马布,本拉利祖马布和梅波利祖马布在降低鼻息肉得分 (NPS) 方面表现出比安慰剂优越性.
在中鼻结局测试-22 (SNOT-22) 得分方面,杜皮卢马布比安慰剂表现优越.
杜皮卢马布和奥马利祖马布在改善鼻塞严重程度 (NCS) 方面优于安慰剂.
杜皮卢马布在NPS (0.92),SNOT-22 (0.70) 和NCS (0.93) 中显示了最高的累积排名 (SUCRA).

结论:

杜皮卢马布被确定为CRSwNP患者最有效的生物治疗方法.
这些发现是基于NPS,SNOT-22分数和NCS的改善.
这项研究提供了有价值的证据,为CRSwNP的治疗决策提供了信息.

关键词:

生物制剂生物制剂生物制剂慢性鼻炎与鼻多.杜比卢马布 (Dupilumab) 的使用情况网络元分析网络元分析

更多相关视频

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Endoscopic Septoplasty with Limited Two-line Resection: Minimally Invasive Surgery for Septal Deviation

Published on: June 20, 2018

相关概念视频

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...